The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Biological Behaviour of Craniopharyngiomas
Abstract
Jakob Erdheim (1874–1937) first described craniopharyngiomas (CPs) as “hypophyseal duct tumours” and postulated the existence of two tumour types based on their histological features: (1) an aggressive type showing similarities to adamantinomas (tumours of the jaw) and (2) a more benign form characterised by the presence of papillary structures. More than a century later, these initial observations have been confirmed; based on their distinct genetic, epigenetic, and histological features, the WHO classifies CPs into two types: adamantinomatous CPs (ACPs) and papillary CPs (PCPs). Considerable knowledge has been generated on the biology of CPs in the last 20 years. Mutations in CTNNB1 (encoding β-catenin) are prevalent in ACP, whilst PCPs frequently harbour mutations in BRAF (p.BRAF-V600E). The consequence of these mutations is the activation of either the WNT/β-catenin (ACP) or the MAPK/ERK (PCP) pathway. Murine models support a critical role for these mutations in tumour formation and have provided important insights into tumour pathogenesis, mostly in ACP. A critical role for cellular senescence has been uncovered in murine models of ACP with relevance to human tumours. Several gene profiling studies of human and murine ACP tumours have identified potential targetable pathways, and novel therapeutic agents are being used in clinical and pre-clinical research, in some cases with excellent results. In this review, we will present the accumulated knowledge on the biological features of these tumours and summarise how these advances are being translated into potential novel treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In ACP, the CTNNB1 mutation is the only consistent genomic alteration identified, which occurs in as many as 95% of cases and determines aberrant nuclear expression of β-catenin and canonical expression of WNT pathway target genes (42-44).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Senescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633
Paracrine roles of cellular senescence in promoting tumourigenesis
Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183
Gonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01992-5 · Cited by 130
Self-citation
Research works printed but not linked: 38
- 10.1007/s00428-015-1798-4 · doi:10.1007/s00428-015-1798-4
- 10.1038/s41572-019-0125-9 · DOI · Paper page
- 10.3171/2016.9.FOCUS16308 · DOI
- 10.1210/jc.2019-01299 · DOI
- 10.1007/s11102-012-0414-8 · DOI
- 10.1016/j.ijrobp.2016.06.2446 · doi:10.1016/j.ijrobp.2016.06.2446
- 10.3389/fendo.2012.00064 · DOI
- 10.1093/jnen/nly083 · doi:10.1093/jnen/nly083
- 10.1515/jpem-2014-0442 · DOI · Paper page
- 10.1186/s40478-016-0321-8 · doi:10.1186/s40478-016-0321-8
- 10.1007/s00401-018-1830-2 · DOI · Paper page
- 10.1016/S0002-9440(10)64477-X · DOI · Paper page
- 10.1530/JOE-15-0145 · DOI
- 10.1007/s00401-005-1004-x · DOI · Paper page
- 10.1007/s00401-014-1270-6 · doi:10.1007/s00401-014-1270-6
- 10.1002/path.1562 · DOI
- 10.1111/j.1750-3639.2008.00180.x · DOI
- 10.1111/nan.12613 · DOI
- 10.1016/j.stem.2013.07.004 · DOI · Paper page
- 10.1073/pnas.1101553108 · DOI · Paper page
- 10.1007/s00401-006-0184-3 · DOI
- 10.1097/01.pas.0000213328.64121.12 · DOI
- 10.1046/j.1365-2559.1997.d01-584.x · doi:10.1046/j.1365-2559.1997.d01-584.x
- 10.1038/ng.2868 · DOI · Paper page
- 10.1093/jnen/nlw116 · DOI
- 10.1038/nature26000 · DOI · Paper page
- 10.1186/s40478-016-0287-6 · DOI · Paper page
- 10.1242/dev.150490 · DOI
- 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
- 10.1080/23723556.2018.1435180 · DOI
- 10.1093/jnci/djv310 · DOI · Paper page
- 10.1007/s11102-015-0663-4 · DOI
- 10.1093/jnen/nlx061 · DOI
- 10.1186/s40478-015-0211-5 · DOI
- 10.3389/fonc.2019.00791 · DOI
- 10.1007/s00401-012-0957-9 · DOI · Paper page
- 10.1530/EJE-14-0934 · DOI
- 10.1530/ERC-18-0538 · DOI
Cited by
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
Metadata
- Authors
- Martinez-Barbera, J. P., & Andoniadou, C. L.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 110
- Issue
- 9-10
- Pages
- 797-804
- ISSN
- 0028-3835
- 1423-0194
- Cited by
- 38
- References
- 6
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biological Behaviour of Craniopharyngiomas. https://app.cochat.ai/papers/10.1159/000506904
- The paper
- Martinez-Barbera, J. P., & Andoniadou, C. L. (2020). Biological Behaviour of Craniopharyngiomas. Neuroendocrinology. https://doi.org/10.1159/000506904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.